NCT04837157View on ClinicalTrials.gov

Evaluation of the Exoskeleton ATLAS 2030 as Robot-assisted Physical Therapy to Children With Neuromuscular Diseases

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

January 31, 2021

Conditions
Cerebral PalsySMA IINeuromuscular Diseases
Interventions
DEVICE

Exoskeleton rehabilitation

The participants will perform physical therapy with the ATLSA2030 device, for 90 minutes per session.

Trial Locations (1)

28500

MarsiCare, Arganda

Sponsors

Lead Sponsor

MarsiBionics
All Listed Sponsors
collaborator

Hospital Universitario La Paz

OTHER

lead

MarsiBionics

INDUSTRY

NCT04837157 - Evaluation of the Exoskeleton ATLAS 2030 as Robot-assisted Physical Therapy to Children With Neuromuscular Diseases | Biotech Hunter | Biotech Hunter